3.6.1. PPARα complexes
The mean RMSD of crystal bound ligand APHM13, FDA approved drug Forasartan and clinical trial Pan-PPAR drug Lanifibranor were 1.94 Å, 2.36 Å, and 1.92 Å, respectively. The combined trajectories of all PPARα complexes during the 200-ns time are illustrated in 